Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Initiation of Cyclosporine and Eltrombopag in Severe Aplastic Anemia
NCT04304820Phase 2Recruiting
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- May 2020
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine, eltrombopag in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started May 2020; status: recruiting.
02
Drugs
cyclosporineeltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT04304820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304820.